<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34906191</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1172</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>Orphanet journal of rare diseases</Title><ISOAbbreviation>Orphanet J Rare Dis</ISOAbbreviation></Journal><ArticleTitle>Leukocyte telomere length and amyotrophic lateral sclerosis: a Mendelian randomization study.</ArticleTitle><Pagination><StartPage>508</StartPage><MedlinePgn>508</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">508</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13023-021-02135-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Observational studies have suggested that telomere length is associated with amyotrophic lateral sclerosis (ALS). However, whether this association is causal remains unclear. In this study, we aimed to explore the causal relationship between leukocyte telomere length (LTL) and ALS by a two-sample Mendelian randomization (MR) approach. Single-nucleotide polymorphisms (SNPs) for LTL were identified through high-quality genome-wide association studies (GWASs). The ALS GWAS summary data (20,806 cases; 59,804 controls) with largest sample size to date was obtained. We adopted the inverse variance weighted (IVW) method to examine the effect of LTL on ALS and used the weighted median method, simple median method, MR Egger method and MR-PRESSO method to perform sensitivity analyses.</AbstractText><AbstractText Label="RESULTS">We found that genetically determined increased LTL was inversely associated with the risk of ALS (odds ratio (OR)&#x2009;=&#x2009;0.846, 95% confidence interval (CI): 0.744-0.962, P&#x2009;=&#x2009;0.011), which was mainly driven by rs940209 in the OBFC1 gene, suggesting a potential effect of OBFC1 on ALS. The results were further confirmed by sensitivity analysis with the MR Egger method (OR&#x2009;=&#x2009;0.647, 95% CI&#x2009;=&#x2009;0.447-0.936, P&#x2009;=&#x2009;0.050). Analyses by the weighted median method (OR&#x2009;=&#x2009;0.893, P&#x2009;=&#x2009;0.201) and simple median method (OR&#x2009;=&#x2009;0.935, P&#x2009;=&#x2009;0.535) also showed a similar trend. The MR Egger analysis did not suggest directional pleiotropy, with an intercept of 0.025 (P&#x2009;=&#x2009;0.168). Neither the influence of instrumental outliers nor heterogeneity was found.</AbstractText><AbstractText Label="CONCLUSIONS">Our results suggest that genetically predicted increased LTL has a causal relationship with a lower risk of ALS. Protecting against telomere loss may be of great importance in the prevention and treatment of ALS.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Kailin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Linjing</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Gan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yajun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Molecular Cardiovascular Sciences (Peking University), Ministry of Education, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fan</LastName><ForeName>Dongsheng</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3129-9821</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, Beijing, China. dsfan2010@aliyun.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China. dsfan2010@aliyun.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Neuroscience, National Health Commission/Ministry of Education, Peking University, Beijing, China. dsfan2010@aliyun.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Orphanet J Rare Dis</MedlineTA><NlmUniqueID>101266602</NlmUniqueID><ISSNLinking>1750-1172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016615" MajorTopicYN="N">Telomere</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Leukocyte telomere length</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34906191</ArticleId><ArticleId IdType="pmc">PMC8670150</ArticleId><ArticleId IdType="doi">10.1186/s13023-021-02135-2</ArticleId><ArticleId IdType="pii">10.1186/s13023-021-02135-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pandya VA, Patani R. Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective. Brain. 2019;143(4):1057&#x2013;1072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7174045</ArticleId><ArticleId IdType="pubmed">31851317</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur KC, Calvo A, Price TR, Geiger JT, Chi&#xf2; A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaiserman A, Krasnienkov D. Telomere length as a marker of biological age: state-of-the-art, open issues, and future perspectives. Front Genet. 2021;11:630186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859450</ArticleId><ArticleId IdType="pubmed">33552142</ArticleId></ArticleIdList></Reference><Reference><Citation>Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, et al. Association between telomere length and risk of cancer and non-neoplastic diseases: a Mendelian randomization study. JAMA Oncol. 2017;3(5):636&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5638008</ArticleId><ArticleId IdType="pubmed">28241208</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo CL, Pilling LC, Kuchel GA, Ferrucci L, Melzer D. Telomere length and aging-related outcomes in humans: a Mendelian randomization study in 261,000 older participants. Aging Cell. 2019;18(6):e13017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6826144</ArticleId><ArticleId IdType="pubmed">31444995</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Yu H. Leukocyte telomere length shortening and Alzheimer's Disease Etiology. J Alzheimers Dis. 2019;69(3):881&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pubmed">31156167</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Khleifat A, Iacoangeli A, Shatunov A, Fang T, Sproviero W, Jones AR, et al. Telomere length is greater in ALS than in controls: a whole genome sequencing study. Amyotroph Lateral Scler Front Degener. 2019;20(3&#x2013;4):229&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6567548</ArticleId><ArticleId IdType="pubmed">30931641</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B, Annunziata A, Fiorentino G, Manfellotto F, D'Alessandro R, Marino R, et al. Telomerase expression in amyotrophic lateral sclerosis (ALS) patients. J Hum Genet. 2014;59(10):555&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">25142509</ArticleId></ArticleIdList></Reference><Reference><Citation>Linkus B, Wiesner D, Messner M, Karabatsiakis A, Scheffold A, Rudolph KL, et al. Telomere shortening leads to earlier age of onset in ALS mice. Aging (Albany NY) 2016;8(2):382&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4789589</ArticleId><ArticleId IdType="pubmed">26978042</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith GD, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">12689998</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangino M, Hwang SJ, Spector TD, Hunt SC, Kimura M, Fitzpatrick AL, et al. Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum Mol Genet. 2012;21(24):5385&#x2013;5394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3510758</ArticleId><ArticleId IdType="pubmed">23001564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura M, Stone RC, Hunt SC, Skurnick J, Lu X, Cao X, et al. Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths. Nat Protoc. 2010;5(9):1596&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pubmed">21085125</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai T-P, Wright WE, Shay JW. Comparison of telomere length measurement methods. Philos Trans R Soc Lond B Biol Sci. 2018;373(1741):20160451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5784071</ArticleId><ArticleId IdType="pubmed">29335378</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams CD, Boutwell BB. A Mendelian randomization study of telomere length and blood-cell traits. Sci Rep. 2020;10(1):12223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376238</ArticleId><ArticleId IdType="pubmed">32699327</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40(3):740&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3147064</ArticleId><ArticleId IdType="pubmed">20813862</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Stoma S, Lotta LA, Warner S, Albrecht E, Allione A, et al. Genome-wide association analysis in humans links nucleotide metabolism to leukocyte telomere length. Am J Hum Genet. 2020;106(3):389&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7058826</ArticleId><ArticleId IdType="pubmed">32109421</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97(6):1268&#x2013;83.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>SNiPA: an interactive, genetic variant-centered annotation browser [Available from: http://www.snipa.org.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4393511</ArticleId><ArticleId IdType="pubmed">25431330</ArticleId></ArticleIdList></Reference><Reference><Citation>Emdin CA, Khera AV, Natarajan P, Klarin D, Zekavat SM, Hsiao AJ, et al. Genetic association of waist-to-hip ratio with cardiometabolic traits, type 2 diabetes, and coronary heart disease. JAMA. 2017;317(6):626&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5571980</ArticleId><ArticleId IdType="pubmed">28196256</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology. 2017;28(1):30&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5133381</ArticleId><ArticleId IdType="pubmed">27749700</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506233</ArticleId><ArticleId IdType="pubmed">28527048</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Tilling K, Smith GD. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11):e1007081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5711033</ArticleId><ArticleId IdType="pubmed">29149188</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion M-JA, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2012;42(5):1497&#x2013;1501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3807619</ArticleId><ArticleId IdType="pubmed">24159078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5976434</ArticleId><ArticleId IdType="pubmed">29846171</ArticleId></ArticleIdList></Reference><Reference><Citation>Niccoli T, Partridge L. Ageing as a risk factor for disease. Curr Biol. 2012;22(17):R741&#x2013;R752.</Citation><ArticleIdList><ArticleId IdType="pubmed">22975005</ArticleId></ArticleIdList></Reference><Reference><Citation>Aviv A, Shay JW. Reflections on telomere dynamics and ageing-related diseases in humans. Philos Trans R Soc Lond B Biol Sci. 2018;373(1741):20160436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5784057</ArticleId><ArticleId IdType="pubmed">29335375</ArticleId></ArticleIdList></Reference><Reference><Citation>Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30(10):e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC115301</ArticleId><ArticleId IdType="pubmed">12000852</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Wang T, Yu X, Zhao H, Zeng P. Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis. Sci Rep. 2020;10(1):12184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376149</ArticleId><ArticleId IdType="pubmed">32699404</ArticleId></ArticleIdList></Reference><Reference><Citation>Codd V, Nelson CP, Albrecht E, Mangino M, Deelen J, Buxton JL, et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet. 2013;45(4):422&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4006270</ArticleId><ArticleId IdType="pubmed">23535734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan M, Qin J, Songyang Z, Liu D. OB fold-containing protein 1 (OBFC1), a human homolog of yeast Stn1, associates with TPP1 and is implicated in telomere length regulation. J Biol Chem. 2009;284(39):26725&#x2013;26731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2785360</ArticleId><ArticleId IdType="pubmed">19648609</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy D, Neuhausen SL, Hunt SC, Kimura M, Hwang SJ, Chen W, et al. Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology. Proc Natl Acad Sci U S A. 2010;107(20):9293&#x2013;9298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2889047</ArticleId><ArticleId IdType="pubmed">20421499</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Makovets S, Matsuguchi T, Blethrow JD, Shokat KM, Blackburn EH. Cdk1-dependent phosphorylation of Cdc13 coordinates telomere elongation during cell-cycle progression. Cell. 2009;136(1):50&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2642970</ArticleId><ArticleId IdType="pubmed">19135888</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho R, Sances S, Gowing G, Amoroso MW, O'Rourke JG, Sahabian A, et al. ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks. Nat Neurosci. 2016;19(9):1256&#x2013;1267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003654</ArticleId><ArticleId IdType="pubmed">27428653</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P, Mizielinska S, Nicoll AJ, Zloh M, Fisher EM, Parkinson G, et al. C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci Rep. 2012;2:1016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3527825</ArticleId><ArticleId IdType="pubmed">23264878</ArticleId></ArticleIdList></Reference><Reference><Citation>Niccoli T, Partridge L, Isaacs AM. Ageing as a risk factor for ALS/FTD. Hum Mol Genet. 2017;26(R2):R105&#x2013;R113.</Citation><ArticleIdList><ArticleId IdType="pubmed">28977441</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu W, Killen M, Culmsee C, Dhar S, Pandita TK, Mattson MP. The catalytic subunit of telomerase is expressed in developing brain neurons and serves a cell survival-promoting function. J Mol Neurosci. 2000;14(1):3&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">10854032</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett ELB, Richardson DS. Sex differences in telomeres and lifespan. Aging Cell. 2011;10(6):913&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pubmed">21902801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, et al. Estrogen activates telomerase. Cancer Res. 1999;59(23):5917&#x2013;5921.</Citation><ArticleIdList><ArticleId IdType="pubmed">10606235</ArticleId></ArticleIdList></Reference><Reference><Citation>Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 2000;407(6803):538&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2670482</ArticleId><ArticleId IdType="pubmed">11029009</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli A, Nanni S, Colussi C, Aiello A, Benvenuti V, Ragone G, et al. Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circ Res. 2008;103(1):34&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">18519947</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Liu T, Liu L, Yao X, Chen L, Fan D, et al. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol. 2020;267(4):944&#x2013;953.</Citation><ArticleIdList><ArticleId IdType="pubmed">31797084</ArticleId></ArticleIdList></Reference><Reference><Citation>Heitzer M, Kaiser S, Kanagaratnam M, Zendedel A, Hartmann P, Beyer C, et al. Administration of 17&#x3b2;-estradiol improves motoneuron survival and down-regulates inflammasome activation in male SOD1(G93A) ALS mice. Mol Neurobiol. 2017;54(10):8429&#x2013;8443.</Citation><ArticleIdList><ArticleId IdType="pubmed">27957680</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeneveld GJ, Van Muiswinkel FL, Sturkenboom JM, Wokke JHJ, B&#xe4;r PR, Van den Berg LH. Ovariectomy and 17&#x3b2;-estradiol modulate disease progression of a mouse model of ALS. Brain Res. 2004;1021(1):128&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">15328040</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson Study Group POETRY Investigators A randomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson&#x2019;s disease. Park Relat Disord. 2011;17(10):757&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pubmed">21824799</ArticleId></ArticleIdList></Reference><Reference><Citation>Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol. 2008;9(11):1048&#x2013;1057.</Citation><ArticleIdList><ArticleId IdType="pubmed">18799354</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>